Building a foundation for the future
- Over £3.3 million invested
Since our founding, the MSA Trust has invested more than £3.3 million into research — funding projects across causes, treatments, biomarkers, clinical care and more. This is made entirely possible by the generosity of our supporters.
- Groundbreaking funded research
We have funded multiple research projects that have advanced understanding of MSA — including studies into DNA changes in brain cells, early biomarkers in blood and spinal fluid, energy production in the brain, and the genetic factors that may increase MSA risk.
- Three Research Fellows trained
Through our Clinical Research Training Fellowship, run in partnership with the Association of British Neurologists, we have supported three exceptional clinician scientists — helping to grow the next generation of MSA specialists.
- Supporting major clinical trials
We have supported recruitment and awareness for multiple clinical trials — including CYPRESS, HORIZON, MASCOT, the Exenatide study and the ATH434 study — helping to connect people living with MSA with studies that could change treatment options.
- PROSPECT-M-UK and ExPRESS
We are a key funder of PROSPECT-M-UK, a major UK-wide study tracking how MSA progresses over time. This study has already led to high-profile publications in neurology journals. We also support the newer ExPRESS study, which is improving early diagnosis across multiple UK sites.
- Annual Research Symposium
Since 2023 we have hosted an annual symposium bringing together MSA researchers from across the UK and internationally — creating the connections and collaborations that accelerate discovery.